← Open Payments lookup

ISAAC OGUNSEYITAN: Open Payments

NPI 1851872816 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,108 in 108 payments from 11 companies in 2025. Trend: 2023 $921 · 2024 $1,093 · 2025 $2,108

Food & beverage: $1,998Education: $109
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.21$586
Teva Pharmaceuticals USA, Inc.23$438
E.R. Squibb & Sons, L.L.C.16$191
Vanda Pharmaceuticals Inc.8$171
Alkermes, Inc.8$150
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)8$142
Otsuka America Pharmaceutical, Inc.6$104
Lundbeck LLC6$100
Axsome Therapeutics, Inc.5$95
ABBVIE INC.4$72

Products named: INGREZZA, COBENFY, UZEDY, FANAPT, ARISTADA, CAPLYTA, AUSTEDO XR, ABILIFY ASIMTUFII.

Industry payments across TX — which companies pay providers there.